Study title:
Weiner-M-A, Leventhal-B-G, Marcus-R, Brecher-M, Ternberg-J, Behm-F-G, Cantor-A, Wharam-M, Chauvenet-A.
Hackensack Medical Center, NJ.
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Ped iatric Oncology Group study.
Journal of clinical oncology : official journal of the American
Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1991, vol. 9, no. 9, p. 1591-8, ISSN: 0732-183X.Weiner-M-A, Leventhal-B-G, Marcus-R, Brecher-M, Ternberg-J, Behm-F-G, Cantor-A, Wharam-M, Chauvenet-A.
Hackensack Medical Center, NJ.
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Ped iatric Oncology Group study.
Journal of clinical oncology ...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|